-
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders Posted on by TrueParallel in News&Uncategorized
-
AskBio Presents Complete Results of Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure at European Society of Cardiology Heart Failure Meeting Posted on by TrueParallel in News&Uncategorized
-
AskBio Announces 15 Presentations at American Society of Gene and Cell Therapy 28th Annual Meeting Posted on by TrueParallel in News&Uncategorized
-
AskBio Elects Dr. Laura Sepp-Lorenzino Independent Member of Board of Directors Posted on by TrueParallel in News
-
AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort Posted on by TrueParallel in News&Uncategorized
-
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy Posted on by TrueParallel in News&Uncategorized
-
First Participant Randomized in Europe in AskBio Phase 2 Gene Therapy Trial for Congestive Heart Failure Posted on by TrueParallel in News
-
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease Posted on by TrueParallel in News&Uncategorized
-
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 Posted on by TrueParallel in News&Uncategorized
-
AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024 Posted on by TrueParallel in News&Uncategorized
